万维提示：
1、投稿方式：在线投稿。
2、期刊网址：https://www.europeanurology.com/
https://www.journals.elsevier.com/european-urology
3、投稿网址：
https://www.editorialmanager.com/EURUROL
4、官网邮箱：platinum@europeanurology.com
5、期刊刊期：月刊，一年出版12期。
2021年5月27日星期四
投稿须知【官网信息】
Guide for Authors
Aims and scope
Elsevier is the publisher of European Urology, the official journal of the European Association of Urology.
European Urology publishes peer-reviewed original articles and topical reviews on a wide range of urological problems. Topics such as oncology, impotence, infertility, pediatrics, lithiasis and endourology, as well as recent advances in techniques, instrumentation, surgery and pediatric urology provide readers with a complete guide to international developments in urology.
Published monthly, European Urology is an important journal for all clinicians and researchers in this field.
All members of the EAU receive the journal as a benefit of their membership. For more information on the European Association of Urology, please go to: http://www.uroweb.org
European Urology
European Urology, 'The Platinum Journal', is the flagship journal of the EU family and has been published continuously since 1975. It is the official journal of the EAU. All published content is peer-reviewed and available in both print and online versions. The journal is sent to all the EAU members digitally and in print (upon request) and receives more than 2 million PDF download requests per year. The Editor-in-Chief is Professor James Catto.
The European Urology impact factor for 2019 is 18.728. Our acceptance rate is around 10% and the average time from submission to first editorial decision after peer review is 12 days. We publish a wide variety of articles in various formats, including review articles, original articles, surgery in motion articles with an accompanying video available online, editorials, editorial comments, interviews, debates, words of wisdom, letters to the editor, and case series.
Review articles, editorials and related articles, and letters to the editor can be read in full text at http://www.europeanurology.com and http://www.sciencedirect.com/science/journal/03022838.
European Urology articles are listed on the PubMed database.
EU-ACME accredited questions are included in every issue of European Urology and can be answered at http://www.eu-acme.org/europeanurology.
Manuscripts should be submitted online via the European Urology online manuscript submission and review system at https://www.editorialmanager.com/EURUROL/
Manuscript Submission
Submission
Manuscripts should be formatted according to the journal instructions and submitted through the appropriate website (https://www.editorialmanager.com/EURUROL/) in Word or LaTeX format for text, and EPS, PDF, JPG, PNG or TIFF for illustrations. Authors may check the status of articles on the submission website. European Urology expects authors to comply with their responsibilities and ensure that they declare all conflicts of interest. We encourage authors to read and adhere to reporting guidelines.
English Language
Manuscripts should be written in English. Authors are free to choose between British English and American English in terms of spelling and grammar as long as the language style is consistent throughout the text. Authors whose native language is not English are expected to have their manuscripts proofread by a professional copyeditor of their choice before submission. Compuscript is the official copyeditor for European Urology.
Statements in articles or opinions expressed by any contributor in any article are not the responsibility of the editors or the publishers. The publisher is not responsible for the loss of manuscripts through circumstances beyond its control.
First submission of Original Articles
Formatting for articles in European Urology is detailed below. However, for the initial submission of Original Articles we will accept manuscripts either fully formatted according to our instructions or unformatted in a broad scientific format. For the latter, we expect an Abstract, Introduction, Methods, Results (with tables and figures), and Discussion within the limits (word count, number of figures/tables and references) of the journal. Reformatting according to our journal specific requirements will then be needed if your article is chosen for revision and further evaluation. We allow initial submissions to be completed with only the corresponding author?s details uploaded onto our submission site. If your manuscript is selected for further review, then uploading of all additional authors will be needed at resubmission. While we will evaluate initial submissions that are not compliant with our journal instructions, we encourage authors to remember the importance of presentation, accuracy, and precision of language. For authors whose primary language is not English, we encourage either using a proofreading service or asking for help from a native English?speaking colleague.
Cover Letter
Although cover letters are not mandatory for submission, authors wishing to include a cover letter with their manuscript are welcome to submit a letter either as a separate file or as part of the manuscript file in the comments section of the submission process. Please note that manuscript files containing a cover letter will be available for reviewers to view if the manuscript is sent for peer review. If the authors prefer to submit a letter for the Editor(s) consideration only, please include the text of the letter in the comments section of the electronic submission process.
Manuscript Components
The manuscript should include a title page, abstract, text, references, and, as appropriate, figure legends, tables, figures, take home message (for original, review, surgery in motion, and brief correspondence articles and platinum opinion editorials), and authorship form (the authorship form can be downloaded here).
Start each of these sections on a new page, numbered consecutively, beginning with the title page. Please check the instructions per article type listed above.
First and last names and the institutional affiliations of all co-authors are required. Manuscripts submitted through the online system should not also be submitted by mail or e-mail. Once the manuscript is submitted online, the corresponding author will receive a manuscript number and will be able to follow the status of the manuscript through the online system.
Manuscript File Formats
For submission and review, acceptable manuscript file formats include Word, WordPerfect, EPS, Text, Postscript, or RTF format. Use 12-point font size, double-space text, and leave right margins unjustified with margins of at least 2.5 cm. Each page should be numbered in the upper right corner, beginning on p. 2. Add continuous line numbering.
Title Page
The title page should include a word count for the text and abstract separately. Authors? full names and affiliations should also be included (see list below). If an author's affiliation has changed since the work was done, the new affiliation should also be listed. For indexing purposes, three to ten keywords should be supplied in alphabetical order (see example below).
Please include:
Authors (first name and initials followed by surname, e.g., Juan X. Alvarez)
Affiliations (if multiple affiliations are listed, indicate with lowercase letter footnotes following the respective authors names)
Contact information for the corresponding author, including full mailing address, telephone number, fax number, and e-mail address
For indexing purposes, three to ten keywords should be supplied (in alphabetical order) in the following format:
Keywords: Benign prostatic hyperplasia; Doxazosin; Lower urinary tract symptoms
Word count of the text: include the abstract but not the references in this count
Word count of the abstract (please remember that abstracts cannot exceed 300 words)
Abstracts
Include a structured abstract of no more than 300 words for original articles, review articles, and surgery in motion articles. (See the specific instructions for preparing structured abstracts.) Abstracts are not required for editorials. No information should be reported in the abstract that does not appear in the text of the manuscript.
Headings
Do not use automatically generated numbering or bulleting systems or hidden text (e.g., for headings, references, footnotes, lists).
Units of Measurement
Units of measurements must conform to the Systeme International (SI): year(s), yr; month(s), mo; days, d; hours, h; minutes, min; seconds, s; grams, g; litres, l; metres, m; sample size, n; probability, p.
Numerals and Abbreviations
Use numerals for all values greater than ten and those followed by a unit; otherwise, spell out (e.g., 18 patients, 0.8 g/ml, 47%, 37°C, six cases). Spell out numbers at the beginning of a sentence. Abbreviations must be defined at first use in each of the following: abstract, text, tables, and figure legends.
Tables
Please see our guidance for the creation of tables and figures at https://www.europeanurology.com/article/S0302-2838(20)30316-X/fulltext. Tables for publication should highlight the most significant data. Try not to duplicate text in tables and vice versa. Tables should be provided as editable Word files and should fit on A4 or letter-sized paper in a font no smaller than 10 point. The column structure should be simple for clarity, and internal gridlines should be hidden. Please make sure that there are not too many columns or rows, and that each contains important data for the report and not too many characters.
Authors should ensure tables are presented in a format suitable for publication. Larger or more complex tables can be made available online as supplementary material. It is impossible to further stipulate an exact table size or content, but consider using supplementary online tables for large datasets or those that may be unsuitable or too large for publication on one journal page.
References
References should be listed in the order in which they are cited in the text and follow a modified American Medical Association (AMA) format. List all authors for publications with up to six authors. For publications with more than six authors, list the first three authors followed by et al.
Example:
[4] Rassweiler JJ, Knoll T, Khrmann KU, et al. Shock wave technology and application: an update. Eur Urol 2011;59:784-96.
Data references
The journal encourages you to cite underlying or relevant datasets in your manuscript by including a data reference in your reference list. Data references should include the following elements: author name(s), dataset title, data repository, version (where available), year, and global persistent identifier. Add [dataset] immediately before the reference so we can properly identify it as a data reference. This identifier will not appear in your published article.
Example of a dataset reference:
[5] Oguro M, Imahiro S, Saito S, Nakashizuka T. Mortality data for Japanese oak wilt disease and surrounding forest compositions, Mendeley Data, v1; 2015. http://dx.doi.org/10.17632/xwj98nb39r.1
Privacy Protection and Informed Patient Consent
Please see Ethical Considerations and Registration of Clinical Trials. Our human participant policy conforms to the uniform requirements of the ICMJE:
"Patients have a right to privacy that should not be infringed without informed consent. Identifying information should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that the patient be shown the manuscript to be published.
Complete anonymity is difficult to achieve, and informed consent for publication should be obtained if there is any doubt. If data are changed to protect anonymity, authors should provide assurance that alterations of the data do not distort scientific meaning.
When informed consent has been obtained it should be indicated in the published article."
For papers that include information or images that could identify or potentially identify individuals, then authors must provide evidence of a proper consent form that the patient, parent, or guardian has signed acknowledging the potential for publication and their awareness of the content. They should be informed about Elsevier publishing policy, in which images and text will be published online and in print and are available for any lawful purpose. The signed consent form should be filed securely in the patient's case notes and the article submitted to European Urology should include this statement indicating that specific consent for publication was obtained: "The patients in this manuscript have given written informed consent to publication of their case details. The editorial office will not store or collect consent forms but reserves the right to enquire about or audit their presence, through proper and legal means.
Funding/Support and Role of Sponsor
All financial and material support for the research and work must be clearly and completely identified as part of the submission process. The specific role of the funding organisation or sponsor in each of the following should be specified: ''design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.'' The corresponding author is responsible for acknowledging this on the authorship form at the time of submission.
Supplementary Files and Data
Information necessary for the article that is in excess of the manuscript restrictions will be considered for online publication or storage. Examples include extensive methodological descriptions, tables of data that are supplementary to the main article thread, details of reporting standards (such as CONSORT flow charts), and other useful figures. This information is to be submitted with the main manuscript and clearly labelled as supplementary material. It will be reviewed by the editorial office and peer reviewers to ensure that it is well presented in an acceptable format and that the contents are necessary. Please use the European Urology formatting style for references and presentation. There is no specific file name for supplementary tables or figures. These may be uploaded under the file name table, figure, or illustration.
Data Access and Responsibility
For all reports (regardless of funding source) containing original data, at least one named author (e.g., the principal investigator) who is independent of any commercial funder should indicate that she or he ''had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.'' This exact statement will be requested as part of the submission process. Modified statements or generic statements indicating that all authors had such access are not acceptable.
For authors reporting molecular results derived using high-throughput technologies, we support the use of minimum reporting standards. For example, for microarrays we support the use of the MIAME 2.0 standards, for deep sequencing we support MIN-Seq, and for real-time PCR we support the MICQ guidelines. Details of these are available at http://www.mged.org/index.html and http://miqe.gene-quantification.info/. We require that datasets derived from these experiments and used for reports within European Urology are deposited online at the appropriate repositories, such as ArrayExpress (http://www.ebi.ac.uk/arrayexpress/) or GEO (http://www.ncbi.nlm.nih.gov/geo/).
Duplicate/Previous Publication or Submission
Manuscripts are considered with the understanding that they have not been published previously in print or electronic format and are not under consideration by another publication or electronic medium. Copies of related or possibly duplicative materials (i.e., those containing substantially similar content or using the same or similar data) that have been previously published or are under consideration elsewhere must be provided at the time of manuscript submission. Publication of the work at an scientific meeting, in abstract form or on a pre-print server that does not conflict with submission to European Urology is allowed but should be disclosed at submission.
Ethical Approval of Studies and Informed Consent
For human or animal experimental investigations, formal review and approval, or review and waiver, by an appropriate institutional review board or ethics committee is required and should be described in the Methods section. For investigators who do not have formal ethics review committees, the principles outlined in the Declaration of Helsinki should be followed. For investigations in human subjects, state in the Methods section the manner in which informed consent was obtained from the study participants (i.e., oral or written).
Personal Communications and Unpublished Data
A signed statement of permission should be included from each individual identified as a source of information in a personal communication or as a source for unpublished data, and the date of communication and whether the communication was written or oral should be specified.
Previous Presentation or Release of Information
A complete report following presentation at a meeting or publication of preliminary findings elsewhere (e.g., an abstract) is eligible for consideration for publication.
Unauthorised Use
Published manuscripts become the permanent property of the EAU and may not be published elsewhere in whole or in part without written permission. Unauthorised use of the European Urology name, logo, or any content for commercial purposes or to promote commercial goods and services (in any format, including print, video, audio, and digital) is not permitted by the EAU.
Data Sharing
We expect authors to freeze datasets at the time of publication and to keep copies of this frozen data for up to 5 years. If the dataset continues to increase, we request that authors maintain the copied, frozen original data necessary for publication. We expect that anonymised versions of this dataset are made available upon request from the editorial office, if necessary, for methodological review or data validation. We also encourage authors to make anonymised data available following reasonable requests from other authors or investigators. We recognise that legal requirements differ between countries and respect such obligations for the submitting authors.
Data Sharing Policy
1. Researchers need to include a data sharing statement: :
a. Data are freely available at a data archive (include web address)
b. Data are available for bona fide researchers who request it from the authors
c. Data are not available to other researchers
2. Option c (data not available to other researchers) is not available for human clinical trials (experimental treatment) without prior agreement of the editors.
3. If data are not available to other researchers, then the authors need to give a reason:
a. Publicly available data
b. Vulnerable population
c. Registry or institutional database of patients providing routinely collected data
d. Other
4. Preparation of this paper did not involve analysis of data.
Ethical Considerations and Registration of Clinical Trials
Trial Registration: As a member of the International Committee of Medical Journal Editors (ICMJE), European Urology requires, as a condition of consideration for publication, prospective registration of all trials in a public trials registry that is acceptable to the ICMJE and that requires the minimum registration data set as described by the ICMJE.
Acceptable trial registries include the following:
http://www.actr.org.au
http://www.clinicaltrials.gov
http://isrctn.org
http://www.trialregister.nl/trialreg/index.asp
http://www.umin.ac.jp/ctr
For this purpose, a clinical trial is any study that prospectively assigns human subjects to intervention or comparison groups to evaluate the cause-and-effect relationship between a medical/surgical intervention and a health outcome. All clinical trials, regardless of when they were completed, and secondary analyses of original clinical trials must be registered before submission of a manuscript based on the trial. For clinical trials starting patient enrolment after July 2005, trials must be registered before the onset of enrolment. The trial registry name, registration identification number, and the URL for the registry should be included at the end of abstract.
All randomised controlled trials require proof of protocol. Authors are expected to provide relevant protocol information upon request. Authors who would not able to provide this information should contact the editorial office upon submission.
CONSORT Flow Diagram and Checklist: Manuscripts reporting the results of randomised controlled trials should include a CONSORT flow diagram showing the progress of patients throughout the trial. The CONSORT checklist should also be completed and submitted with the manuscript and can be found at http://www.consort-statement.org/consort-statement/checklist.
Biomarkers: For manuscripts reporting biomarkers and biological markers, European Urology encourages adherence to the REMARK reporting criteria. Please refer to REMARK guidelines.
Reporting of Research Using Animals
European Urology asks authors to refer to the ARRIVE guidelines when reporting research were animals were involved. Access the ARRIVE guidelines here.
Copyediting
Accepted manuscripts will be copyedited to make sure they conform to the journal style. The final version of the manuscript following copyediting will be sent back to the author only if specific queries need clarification.
Article Types
Original Articles
These manuscripts typically report on basic and translational research, epidemiology, pathophysiology, diagnosis, medical or surgical treatment, and minimally invasive therapy related to urological diseases.
Each manuscript should clearly state an objective or hypothesis; the design and methods (including the study setting and dates, patients or participants with inclusion and exclusion criteria and/or participation or response rates, or data sources, and how these were selected for the study); the essential features of any interventions; the main outcome measures; the main results of the study; a discussion section placing the results in context with the published literature and addressing study limitations; and the conclusions. Data included in research reports should be as timely and current as possible.
We encourage authors to report outcomes and complications in a structured manner. We advise the use of peer-reviewed documents to guide this, such as Mitropoulous et al. Reporting and Grading of Complications After Urologic Surgical Procedures: An ad hoc EAU Guidelines Panel Assessment and Recommendations or other recognised reporting structures.
Please see our guidance on First submission of Original Articles (above). At first submission, we will accept manuscripts fully formatted according to our instructions or unformatted in a broad scientific format. For the latter, we expect an Abstract, Introduction, Methods, Results (with tables and figures), and Discussion within the limits (word count, number of figures/tables and references) of the journal. Reformatting according to our journal specific requirements will then be needed if the article is chosen for revision and further evaluation. We allow initial submissions to be completed with only the corresponding author's details uploaded onto our submission site. If the manuscript is selected for further review, then uploading of all additional authors will be needed at resubmission.
Text
The text of the manuscript should be divided as follows: Introduction; Materials (Patients) and Methods; Results; Discussion; Conclusions.
Word count
The maximum word count is 3000, including the abstract but not including the references, tables, figures, or legends (i.e. abstract maximum 300 words and text maximum 2700 words).
The number of references should be limited to 40.
Take Home Message
Two or three sentences (no more than 40 words) summarising the main message expressed in the article should be uploaded as a separate file or included at the end of the manuscript text. This separate file will be mandatory when uploading the revised version.
Downloads: Original Article Abstract
The format of the original article should be as follows:
Provide a structured abstract no longer than 300 words with the following sections: Background; Objective; Design, Setting, and Participants; Intervention (include if there are any); Outcome Measurements and Statistical Analysis; Results and Limitations; Conclusions; and Patient Summary (the Patient Summary is an obligatory section of the manuscript. Submissions not including a patient summary will be returned to the corresponding author).
Original articles must be no longer than 3000 words (300 abstract + 2700 body not including the reference list, tables, figures, or legends). References are limited to 40. Please limit tables and figures to six. Additional tables, figures, or appendices may be submitted as supplementary material but will be published online only.
For brevity, parts of the abstract may be written as phrases rather than complete sentences. Each section should include the following content (see abstract structure details below):
Background: The abstract should begin with a sentence or two explaining the clinical (or other) importance of the study question.
Objective: State the precise objective or study question addressed in the manuscript (e.g., ''To determine whether ?''). If more than one objective is addressed, the main objective should be indicated, and only key secondary objectives stated.
Design, Setting, and Participants: Describe the basic design of the study. State the years of the study and the duration of follow-up. Describe the study setting to assist readers in determining the applicability of the report to other circumstances, for example, general community, a primary care or referral centre, private or institutional practice, or ambulatory or hospitalised care. State the clinical disorders, important eligibility criteria, and key sociodemographic characteristics of patients. The numbers of participants and how they were selected should be provided. In follow-up studies, the proportion of participants who completed the study must be indicated. In intervention studies, the number of patients withdrawn because of adverse effects should be given. For selection procedures, these terms should be used, if appropriate: random sample (where random refers to a formal, randomised selection in which all eligible individuals have a fixed and usually equal chance of selection); population-based sample; referred sample; consecutive sample; volunteer sample; convenience sample.
Intervention(s): The essential features of any interventions (surgical or medical) should be described. The nonproprietary drug or device names should be used unless the specific trade name is essential to the study.
Outcome Measurements and Statistical Analysis: Indicate the primary and secondary study outcome measurement(s) and the main statistical analysis.
Results and Limitations: The main outcomes of the study should be reported and quantified. Complications or sequelae of the interventions used must be detailed. Particular attention must be paid to estimates of the treatment effect and confidence intervals and not just to p values. All randomised controlled trials should include the results of intention-to-treat analysis, and all surveys should include response rates. Limitations of the study should be acknowledged.
Conclusions: Provide only conclusions from the study directly supported by the results, along with implications for clinical practice, avoiding speculation and overgeneralisation. Indicate whether additional studies are required before the results should be used in usual clinical settings. Give equal emphasis to positive and negative findings of equal scientific merit.
Patient Summary: Please include at the end of the abstract two or three short sentences in plain English to describe your findings to a nonmedical audience. For example: "In this report we looked at outcomes for invasive bladder cancer in a large European population. We found that outcomes varied with patient age and treating centre. We conclude that the best outcomes are seen in younger patients treated at high-volume hospitals. You will also be asked to include this summary in the Additional Information section of the submission process.
Please note that if your study is animal-based, the patient summary should state how you anticipate the results of your study would affect a patient population.
……
更多详情：
https://www.elsevier.com/journals/european-urology/0302-2838/guide-for-authors#txt1500
